Why the study?
What is the diagnostic value of fluid cytology and the survival outcome in lung cancer patients with symptomatic pericardial effusion?
Population
20 lung cancer patients with symptomatic pericardial effusion treated conservatively between 1975-1988
Design
Case_series
Follow-up
up to 9 months
Authors
Loading...
Cytology may aid diagnosis in lung cancer pericardial effusion; leaves open prognostic implications from this small case series.
What is the diagnostic value of fluid cytology and the survival outcome in lung cancer patients with symptomatic pericardial effusion?
Pericardial effusion in lung cancer indicates rapid tumor progression and short survival, with fluid cytology providing an accurate diagnostic tool.
Edoute et al. (1990) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: